Skip to main content

Table 3 Patients’ characteristics in surgical and non-surgical groups

From: Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer

Item

Surgical resection

No surgical resection

p value

Median age

50.5 (IQR 41–57)

54 (IQR 43–59)

0.8

Males %

9 (69.3%)

18 (47.2%)

0.2

Median performance status

1 (IQR 0.5–1)

1 (IQR 1–2)

0.3

% right-sided primary

3 (23.1%)

8 (21.1%)

0.8

Median number metastatic site

1 (IQR 1–2)

2 (IQR 1–3)

0.09

% mutant KRAS

7 (53.8%)

13 (34.2%)

0.3

% best response

11 (84.6%)

18 (56.2%)

0.3

  1. IQR interquartile range